Hepatocytes prepared from rats treated with dexamethasone for 2 or 3h and maintained in the presence of 10 Mm-dexamethasone in the preparation and incubation buffers showed significantly elevated rates of gluconeogenesis compared with those prepared from control animals. Dexamethasone treatment also increased the sensitivity of the cells to glucagon and the catecholamines. Analysis of the concentrations of metabolites in the gluconeogenic pathway indicated that dexamethasone decreased the intracellular concentration of pyruvate and increased those of phosphoenolpyruvate, acetyl-CoA and citrate, suggesting a stimulation of the reaction(s) converting pyruvate into phosphoenolpyruvate. This was substantiated by analysis of the pattern of metabolites found in the mitochondrial compartment after digitonin fractionation of the cells. Inclusion of 3-mercaptopicolinate in the incubation enhanced the effect of the hormone on the distribution of metabolites. Thus, in the absence of an effect of the steroid at the level of phosphoenolpyruvate carboxykinase or pyruvate kinase, dexamethasone treatment still increased the formation of malate, aspartate and citrate from pyruvate, indicating a stimulation in the intact cell of pyruvate carboxylase. It is suggested that the stimulation of pyruvate carboxylase is a result of a general activation of mitochondrial function, with an increase in the intramitochondrial concentrations of acetyl-CoA and ATP, a decrease in glutamate and an enhanced intramitochondrial [ATP]
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It is clearly established that glucocorticoids play a major role in the control of gluconeogenesis (Long et al., 1940; Haynes, 1962; Rinard et al., 1969; Exton et al., 1970 Exton et al., , 1972 Exton et al., , 1973 ). In the starved or diabetic animal, adrenalectomy decreases the rate of glucose synthesis by the liver and markedly lowers the degree of stimulation by glucagon and adrenaline (Exton et al., 1972 (Exton et al., , 1973 (Exton et al., , 1976 Friedmann et al., 1967) . Replacement treatment with glucocorticoids, either in vivo or in vitro, enhances the rate of gluconeogenesis in both liver slices (Haynes, 1962; Rinard et al., 1969) and the perfused liver (Exton et al., 1972 (Exton et al., , 1973 (Exton et al., , 1976 and restores the sensitivity to glucagon and catecholamines (Friedmann et al., 1967; Exton et al., 1972) . Analysis of the concentrations of the intermediary metabolites in the gluconeogenic pathway have shown that adrenalectomy results in an increase in the tissue concentration of lactate and pyruvate and a decrease in phosphoenolpyruvate, whereas treatment with glucocorticoids produces the oppo-* To whom reprint requests should be addressed. site effects and normalizes the metabolite pattern (Rinard et al., 1969; Exton et al., 1973 Exton et al., , 1976 . From these data it has been suggested that a major site of action of the steroid hormones residues at the level of the conversion of pyruvate into phosphoenolpyruvate, either at the pyruvate carboxylase reaction (Rinard et al., 1969) or, in the absence of any effect of the steroids on the total pyruvate carboxylase activity of the tissue, at the level of phosphoenolpyruvate carboxykinase (Exton et al., 1976) . Although the induction of phosphoenolpyruvate carboxykinase by glucocorticoids is firmly established (Foster et al., 1966; Barnett & Wicks, 1971; Gunn et al., 1975; Krone et al., 1975 Krone et al., , 1976 , several reports suggest that this may not account for the earliest effects of glucocorticoids on gluconeogenesis. Gunn et al. (1975) have shown that in the normal animal glucocorticoids stimulate gluconeogenesis before any effect on phosphoenolpyruvate synthesis occurs. Similarly, in the adrenalectomized animal, the restoration of gluconeogenesis after glucocorticoid treatment occurs before that of phosphoenolpyruvate carboxykinase Vol. 219 (Exton et al., 1973) . In contrast, the studies by Haynes and co-workers (Adam & Haynes, 1969; and those in the preceding paper (Martin et al., 1984) have suggested that alterations in the rate of mitochondrial pyruvate carboxylation may be important in explaining the earliest effects of glucocorticoids on gluconeogenesis. The onset of this response correlates temporally with the enhancement of gluconeogenesis (Rinard et al., 1969; , does not require the induction of pyruvate carboxylase and appears to be mediated by alterations in the intramitochondrial concentrations of effector molecules (Martin et al., 1984) .
The purpose of the present study was twofold: firstly, to determine whether treatment of the normal fed rat with glucocorticoids over the short term results in a direct stimulation of gluconeogenesis which is independent of the circulating concentrations of glucagon and the catecholamines; secondly, to 3 h before the preparation of the hepatocytes as indicated. After the appropriate time, the animals were anaesthetized with sodium pentobarbital (60mg/kg), and hepatocytes were prepared as described previously . Batches of collagenase were carefully screened in terms of metabolic function and Trypan Blue exclusion, and only those producing cells of which over 85% excluded the dye were used. Dexamethasone sodium phosphate (final concn. 10 gM) was included in both the perfusion medium and all further media used for the preparation and incubation of hepatocytes from the steroid-treated animals. The preparation of the hepatocytes took approx. 1 h, after which they were resuspended to a final concentration of 120-140mg wet wt./ml in KrebsRinger bicarbonate buffer, pH 7.4 (Krebs & Henseleit, 1932) , containing 1.5% (w/v) gelatin, 2mM-glucose and 0.1% (w/v) bacitracin. Except where indicated, 2ml portions of the cell suspensions were preincubated in 25 ml Erlenmeyer flasks, gassed with 02/CO2 (19: 1), for a period of 30min before the addition of a pyruvate/lactate mixture (final concns. 2.5mm of each). When the rate of gluconeogenesis was to be determined, [2-'4C]pyruvate (sp. radioactivity 5OmCi/mol) replaced the unlabelled pyruvate in the pyruvate/lactate mixture. Glucagon and adrenaline were added simultaneously with the pyruvate/lactate mixture where appropriate, to the final concentrations indicated. The incubation was continued for a further 15 min after the addition of the substrate. The rate of gluconeogenesis from [2-14C]pyruvate was determined as described previously . The concentrations of metabolites were determined at the end of the incubation period by using the digitonin fractionation procedure described by Siess et al. (1976) . The final concentration of digitonin was 3 mg/ml, and AR 200 silicone oil was used instead of a mixture of AR 200 and AR 20. For the determination of the total cellular metabolite concentrations, the digitonin was omitted from the fractionation buffer and the intact hepatocytes were sedimented through oil in an Eppendorf micro-centrifuge. In experiments where 3-mercaptopicolinate was used in the incubation, this was added after the first 15 min of the preincubation period. The intramitochondrial concentrations of metabolites were calculated by assuming a mitochondrial volume of 0.166 ml/g dry wt. of cells (Siess et al., 1976) . There was no difference in the intramitochondrial volumes of mitochondria isolated from control and dexamethasone-treated animals (Martin et al., 1984) . Metabolites were analysed in neutralized HC104 extracts of the cells and mitochondrial fractions. Citrate was assayed as described by Passonneau & Brown (1974) , malate as described by Goldberg & Passonneau (1974) , pyruvate by the method of Passonneau & Lowry (1974) , aspartate by the method of Williamson & Corkey (1969) and phosphoenolpyruvate by the method of Czok & Lamprecht (1974) . Other metabolites were measured as described previously .
Results are expressed as means+ S.E.M. for the numbers of different cell preparations given in parentheses. Statistical analysis of results was performed by a paired Student's t test.
Results and discussion
EJfect of dexamethasone treatment of the rat on gluconeogenesis in subsequently isolated hepatocytes Previous studies have indicated that glucocorticoids play a permissive role in the regulation of gluconeogenesis (Friedmann et al., 1967; Exton et al., 1972) . Eigler et al. (1979) have demonstrated that infusion of cortisol into the intact dog to produce a physiological elevation in the plasma concentration of cortisol, which in itself did not stimulate gluconeogenesis, potentiated the action of both the catecholamines and glucagon on glucose synthesis. Similarly, Stumpo & Kletzien (1981) have shown that, in primary cultures of hepatocytes, dexamethasone potentiated the action of glucagon to stimulate gluconeogenesis, although the steroid alone had only a minimal effect over the first 5 h of treatment. In the preceding paper (Martin et al., 1984) and earlier studies, it has been postulated that the enhancement of mitochondrial metabolism observed after treatment of the rat for 3 h is important in the stimulation of gluconeogenesis and may account for the earliest effects of the steroids on glucose synthesis (Adam & Haynes, 1969; Allan et al., 1983; Martin et al., 1984) . Therefore the effect of dexamethasone treatment of the rat on the rate of glucose synthesis by subsequently isolated hepatocytes has been examined to determine whether, under the conditions of hormone treatment used in the mitochondrial studies, a stimulation of the pathway actually occurs either directly or as a result of a change in the sensitivity of the cells to physiological concentrations of glucagon or catecholamines. The results are shown in Table 1 . Treatment of the rat with dexamethasone for 2 h in vivo before the preparation of the hepatocytes and I lh in vitro during the preparation and incubation resulted in a 44% increase over the basal rate of gluconeogenesis in hepatocytes prepared from control animals and incubated in the absence of dexamethasone. The effect of dexamethasone treatment was maintained when the hepatocytes were incubated in the presence of both submaximal and maximal concentrations of glucagon and adrenaline. The combination of the glucocorticoid with either of the other two gluconeogenic hormones potentiated their effects, although for glucagon this was only significant at the lowest concentration. Therefore the results indicate that glucocorticoids have a direct effect on gluconeogenesis in the normal fed rat under our experimental conditions, while at the same time they increase both the sensitivity and the magnitude of the response to both glucagon and catecholamines. The magnitude of the response to dexamethasone was considerably greater than that reported in the primary culture system and more rapid in time of onset (Stumpo & Kletzien, 1981) , although it was comparable with results of the study in vitro by . Table 2 shows the effect of dexamethasone treatment on the sensitivity of the cells to glucagon and adrenaline. The results indicate that the permissive effect of dexamethasone occurs in the normal fed rat in addition to that observed in the starved adrenalectomized animal (Friedmann et al., 1967; Exton et al., 1972) and that the sensitivity to both glucagon and adrenaline was significantly increased (P < 0.05). There was an approx. 5-fold decrease in the concentration of either hormone required to achieve a maximal response, and the con- Table 3 . Except for the intracellular concentration of pyruvate, the values found for the other metabolites in the hepatocytes prepared from the control rats are comparable with those reported previously by Siess et al. (1977) . The lower value obtained for pyruvate probably reflects the lower substrate concentration used in the present study, 2.5 mM-pyruvate plus 2.5 mM-lactate as opposed to 11.9 mM-lactate. In agreement with the study by Rinard et al. (1969) , using liver slices prepared from starved adrenalectomized rats, and those by Exton et al. (1973 Exton et al. ( , 1976 (Foster et al., 1966; Barnett & Wicks, 1971; Gunn et al., 1975; Krone et al., 1975 Krone et al., , 1976 Johnson et al., 1981) . To distinguish between these three possibilities, the concentrations of metabolites in the mitochondrial fractions of cells prepared from control animals and animals treated with dexamethasone were measured. The results are shown in Table 4 . The concentrations of metabolites in the mitochondrial fraction of control cells determined in this study are comparable with those reported previously by Siess et al. (1977 Siess et al. ( , 1978 , the major exception being the intramitochondrial concentrations of ATP and ADP, which are closer to the values reported previously by Bryla et al. (1977) and Titheradge et al. (1979) . Dexamethasone treatment significantly decreased the intramitochondrial concentration of pyruvate (P<0.0l) and increased those of malate and citrate. It also resulted in a significant increase in the intramitochondrial concentration of ATP (P < 0.01), with no change in the ADP content, and thus increased the intramitochondrial [ATP]/ [ADP] ratio, in agreement with the known effects Hormone Glucagon Adrenaline Table 3 . Effect of dexamethasone treatment on the concentrations of metabolites in isolated hepatocytes Dexamethasone or vehicle was administered to the rat 3 h before the preparation of hepatocytes as described in the Experimental section. The preincubation step was omitted and glucose synthesis was measured over the first 15 min of the incubation. The rates for cells prepared from control and dexamethasone-treated animals were 768 + 49 and 1025 + 52 (12) nmol of glucose/min per g dry wt. of cells respectively. The metabolites were measured as described in the Experimental section after centrifugation through silicone oil at the end of the 15min incubation period: *P < 0.05, **P<0.01, ***P<0.001 for difference from controls. of the other gluconeogenic hormones on adenine nucleotide metabolism (Siess et al., 1977 (Siess et al., , 1978 Bryla et al., 1977; Titheradge et al., 1979 (Keech & Utter, 1963; Seubert et al., 1968; Stucki et al., 1972; von Glutz & Walter, 1976) and confirm the conclusions drawn from studies with isolated mitochondria (Adam & Haynes, 1969; Martin et al., 1984) . The major difference between the conclusions drawn from the present study and that with the isolated organelles (Martin et al., 1984) resides in the importance of glutamate. Glutamate has been reported to be an effective inhibitor of pyruvate carboxylase, with a Ki of approx. 5 mM (Scrutton & White, 1974) , and it is apparent from the data in Table 4 and the results of Siess et al. (1977 Siess et al. ( , 1978 The experimental protocol was as described in Fig. 1 . The final concentration of 3-mercaptocicolinate was 500 mM. Effect of 3-mercaptopicolinate on metabolite concentrations in control and dexamethasone-treated hepatocytes To substantiate the claim that the increased flux through pyruvate carboxylase after dexamethasone treatment of the rat is a result of a direct activation of pyruvate carboxylase itself and is independent of alterations in the gluconeogenic pathway distal to the enzyme, 3-mercaptopicolinate was used to inhibit gluconeogenesis at the level of phosphoenolpyruvate carboxykinase. The cells were incubated with 3-mercaptopicolinate for 15 min before the addition of the gluconeogenic substrates. It was found that increasing the concentration of the inhibitor resulted in a progressive decline in glucose synthesis and diminished the effect of hormone treatment, until, at a final concentration of 500 uM-3-mercaptopicolinate, the rate of gluconeogenesis in the control was lowered to approx. 15% of the initial activity and the effect of dexamethasone was completely abolished. Table 5 shows the effect of dexamethasone on the concentrations of metabolites in both the whole cell and the mitochondrial fraction in the presence and absence of 500 uM-3-mercaptopicolinate. In the absence of inhibitor, the glucocorticoid significantly increased the rate of glucose synthesis by the cells (P <0.01), and this was reflected in a decrease in the total cellular and mitochondrial pyruvate concentrations. Malate and aspartate showed a small but insignificant increase in both the intact cell and the mitochondrial compartment, whereas the concentration of citrate was significantly elevated (P<0.05). As shown by Jensen et al. (1983) , treatment of the cells with 3-mercaptopicolinate increased the intracellular concentrations of pyruvate, citrate, malate and aspartate, as a consequence of the decreased utilization of oxaloacetate by phosphoenolpyruvate carboxykinase. Despite the lowered rate of gluconeogenesis and the absence of any hormone effect on glucose synthesis from [2-14C]pyruvate, the effect of dexamethasone treatment on the pattern of metabolites was still apparent and even enhanced. The steroid increased the utilization of pyruvate within the cell and enhanced the production of malate, aspartate and citrate in both the tissue as a whole and the mitochondrial fraction. Thus, in the absence of an effect of the glucocorticoid at the level of phosphoenolpyruvate carboxykinase or pyruvate kinase, the change in metabolite pattern is evidence in favour of a stimulation of the pyruvate carboxylase reaction in vivo.
In conclusion, the data presented above indicate that glucocorticoids are capable of stimulating the gluconeogenic pathway in the normal fed rat both directly and as a result of increasing the sensitivity of the cells to physiological concentrations of glucagon and adrenaline. The mechanism behind the stimulation of glucose synthesis by dexamethasone can be explained, in part at least, by an increased rate of pyruvate carboxylation within the mitochondria. This study corroborates the conclusions drawn from studies using the isolated organelles and suggests that the activity of pyruvate carboxylase is restrained within the mitochondria by the intramitochondrial concentrations of effector molecules, and that glucocorticoids, in common with other gluconeogenic hormones, relieve this restraint by decreasing the intramitochondrial concentration of glutamate and increasing those of acetyl-CoA and ATP.
